The cost of cancer care management for a 24 month period increases substantially from stage I ($71,000) to stage IV ($182,000).
The later the disease is diagnosed, the more expensive the cost will be. The economic burden of those increasing costs is felt across the board, including patients, their families, government and insurance companies (1).
It is substantially cheaper and much more beneficial to all: patients, healthcare providers, and insurance companies to adopt monitoring early cancer relapse to avoid the huge and increasing costs of cancer management.